This federal contract award, valued at $1,924.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Barhemsys 5 mg/2 ml vial, a medication used in the treatment of postoperative nausea and vomiting. The contract is a firm-fixed-price delivery order with a completion date of December 5, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 3/5/25, 9:52 AM